Brett Sandercock - 07 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
07 Nov 2022
Transactions value $
-$848,068
Form type
4
Filing time
09 Nov 2022, 16:03:56 UTC
Previous filing
22 Aug 2022
Next filing
23 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$848K -4K -3.63% $212.02 106K 07 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $212 to $212.04. The price reported above reflects the weighted average sale price.
F2 Includes 30.50 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.